HealthShares™ Composite ETF (HHQ) is one in a series of HealthShares™ ETFs that are organized by therapeutic categories in pharmaceuticals, healthcare services, life sciences and biotechnology. HHQ seeks investment results that correspond to the performance, before the Fund’s fees and expenses, of HealthShares™ Composite Index, an equity index of publicly traded common stocks and ADRs. The Composite Index invests in healthcare, life sciences and/or biotechnology companies that have been included in the HealthShares™ Autoimmune-Inflammation Index, the HealthShares™ Cancer Index, the HealthShares™ Cardio Devices Index, the HealthShares™ Cardiology Index, the HealthShares™ Dermatology and Wound Care Index, the HealthShares™ Diagnostics Index, the HealthShares™ Emerging Cancer Index, the HealthShares™ Enabling Technologies Index, the HealthShares™ GI/Gender Health Index, the HealthShares™ Infectious Disease Index, the HealthShares™ Metabolic-Endocrine Disorders Index, the HealthShares™ Neuroscience Index, the HealthShares™ Ophthalmology Index, the HealthShares™ Orthopedic Repair Index, the HealthShares™ Patient Care Services Index and the HealthShares™ Respiratory/Pulmonary Index (collectively, the “Composite Eligible Indexes”) by the Index Administrator and therefore are included in the HealthShares™ Composite Index. The HealthShares™ Composite Index will consist of the 80 largest companies by market capitalization that are part of the Composite Eligible Indexes.
HHQ employs a low-cost passive management investment approach designed to track the performance of the HealthShares™ Composite Index. Normal brokerage fees apply. HHQ will generally invest at least 90% of its assets in common stocks of companies in the underlying Index.
HHQ intends to pay out any dividends from its net investment income annually, and plans to distribute any net capital gains annually.
XShares Advisors LLC is the investment advisor for HHQ. Bank of New York acts as custodian and administrator.
| Market data | |
|---|---|
| Market Price (07/06/2007)* | $27.63 |
| Change | $0.05 |
| Volume | 900 |
| NAV History Premium/Discount Chart | |
| Details | |
|---|---|
| NAV as of 07/06/2007 | $27.4610 |
| NAV Change | $0.1315 |
| Shares Outstanding | 100,200 |
| Total Cash | $4,209.86 |
| Estimated Cash | $4,202.78 |
| Bid as of 07/05/2007 | $27.51 |
| Mid point as of 07/05/2007 | $27.55 |
| Ask as of 07/05/2007 | $27.60 |
| Market Price as of 07/06/2007* | $27.63 |
| Change | $0.05 |
| Premium/Discount*** | N/A |
| Yield | N/A |
| Expense ratio as of 07/06/2007 | 0.75% |
| Inception date | 03/12/2007 |
| Ticker symbol | HHQ |
| IOPV** ticker symbol | HHQ.IV |
* Last Sale.
** Indicative Optimized Portfolio Value.
*** Bid/Ask Midpoint versus NAV.